Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMFIBROZIL for Dyslipidaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 37 adverse event reports in the FDA FAERS database where GEMFIBROZIL was used for Dyslipidaemia.

Most Reported Side Effects for GEMFIBROZIL

Side Effect Reports % Deaths Hosp.
Drug hypersensitivity 242 22.2% 1 1
Drug ineffective 77 7.1% 3 27
Rhabdomyolysis 63 5.8% 4 50
Fatigue 60 5.5% 8 9
Drug interaction 59 5.4% 12 24
Myalgia 58 5.3% 7 17
Nausea 54 5.0% 8 19
Acute kidney injury 52 4.8% 2 39
Diarrhoea 43 4.0% 17 7
Rash 41 3.8% 8 3
Completed suicide 40 3.7% 40 3
Vomiting 39 3.6% 17 11
Malaise 38 3.5% 7 9
Blood triglycerides increased 35 3.2% 0 0
Hypertriglyceridaemia 34 3.1% 4 31

Other Indications for GEMFIBROZIL

Product used for unknown indication (208) Hypertriglyceridaemia (112) Hyperlipidaemia (61) Hypercholesterolaemia (50) Blood cholesterol increased (48) Blood cholesterol abnormal (32) Blood triglycerides increased (32) Blood cholesterol (17) Diffuse large b-cell lymphoma (16) Familial hypertriglyceridaemia (15)

Other Drugs Used for Dyslipidaemia

ATORVASTATIN (4,796) ROSUVASTATIN (2,032) SIMVASTATIN (1,253) EVOLOCUMAB (1,056) EZETIMIBE (787) PRAVASTATIN (747) FENOFIBRATE (606) EZETIMIBE\SIMVASTATIN (302) ATORVASTATIN\EZETIMIBE (239) DEVICE (172)

Related Pages

GEMFIBROZIL Full Profile All Dyslipidaemia Drugs GEMFIBROZIL Demographics GEMFIBROZIL Timeline